1. Aspirin for Prevention of Preeclampsia

   • A. Atallah
   • E. Lecarpentier
   • V. Tsatsaris

   Therapy in Practice Open access 16 October 2017 Pages: 1819 - 1831

   

2. A Review of Food–Drug Interactions on Oral Drug Absorption

   • Jianyuan Deng
   • Xiao Zhu
   • Tai Ning Lam

   Review Article 26 October 2017 Pages: 1833 - 1855

   

3. Deutetrabenazine: A Review in Chorea Associated with Huntington’s Disease

   • Young-A Heo
   • Lesley J. Scott

   Adis Drug Evaluation 27 October 2017 Pages: 1857 - 1864

4. Tocilizumab: A Review in Rheumatoid Arthritis

   • Lesley J. Scott

   Adis Drug Evaluation Open access 01 November 2017 Pages: 1865 - 1879

5. Meningococcal Quadrivalent Tetanus Toxoid Conjugate Vaccine (MenACWY-TT; Nimenrix^®): A Review

   • Sohita Dhillon
   • David Pace

   Adis Drug Evaluation 01 November 2017 Pages: 1881 - 1896

6. Pomalidomide: A Review in Relapsed and Refractory Multiple Myeloma

   • Sheridan M. Hoy

   Adis Drug Evaluation 06 November 2017 Pages: 1897 - 1908

7. Ciclosporin Ophthalmic Emulsion 0.1%: A Review in Severe Dry Eye Disease

   • Sheridan M. Hoy

   Adis Drug Evaluation 06 November 2017 Pages: 1909 - 1916

8. Tivozanib: First Global Approval

   • Esther S. Kim

   AdisInsight Report 03 October 2017 Pages: 1917 - 1923

9. Comment on: “Targeting the PGD₂/CRTH₂/DP₁ Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives”

   • İnsu Yılmaz
   • Murat Türk

   Letter to the Editor 04 October 2017 Pages: 1925 - 1926

10. Authors’ Reply to Yilmaz and Türk: “Targeting the PGD₂/CRTH₂/DP₁ Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives”

    • Maciej Kupczyk
    • Piotr Kuna

    Letter to the Editor 04 October 2017 Pages: 1927 - 1928